LGVNR (LGVNR) News
Track canonical SquawkNews coverage tagged to LGVNR, LGVNR. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 6 indexed stories across 6 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
LGVN LGVNR - Longeveron Announces Topline Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS)
LGVN LGVNR - Longeveron Announces Topline Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS)
NEWS | Sep 16, 2026, 09:27 PM UTC
L
LGVN LGVNR - Longeveron to Present at the H.C. Wainwright 28th Annual Global Investment Conference
LGVN LGVNR - Longeveron to Present at the H.C. Wainwright 28th Annual Global Investment Conference
EQUITY | Sep 03, 2026, 01:15 PM UTC
L
Longeveron Announces 1-for-10 Reverse Stock Split
Longeveron announced a 1-for-10 reverse stock split for LGVNR.
EQUITY | Aug 24, 2026, 08:05 PM UTC
M
Longeveron appoints Nirav Jhaveri as Chief Financial Officer
Longeveron (LGVNR) appoints Nirav Jhaveri as its Chief Financial Officer, according to the company’s announcement.
EQUITY | Aug 19, 2026, 08:05 PM UTC
L
Longeveron Announces Q2 Financial Results
Longeveron announces 2026 second quarter financial results and provides business update
EARNINGS | Aug 12, 2026, 08:05 PM UTC
L
LGVN LGVNR - Longeveron to Report 2026 Second Quarter Financial Results and Host Conference Call on August 12, 2026
LGVN LGVNR - Longeveron to Report 2026 Second Quarter Financial Results and Host Conference Call on August 12, 2026
EARNINGS | Aug 03, 2026, 08:05 PM UTC